143 related articles for article (PubMed ID: 22587744)
1. Serum carbohydrate antigen 125 levels in nonischemic dilated cardiomyopathy: a useful biomarker for prognosis and functional mitral regurgitation.
Karaca O; Guler GB; Guler E; Gunes HM; Alizade E; Agus HZ; Gol G; Kahveci G; Esen O; Esen AM; Turkmen M
Congest Heart Fail; 2012; 18(3):144-50. PubMed ID: 22587744
[TBL] [Abstract][Full Text] [Related]
2. Tenting area reflects disease severity and prognosis in patients with non-ischaemic dilated cardiomyopathy and functional mitral regurgitation.
Karaca O; Avci A; Guler GB; Alizade E; Guler E; Gecmen C; Emiroglu Y; Esen O; Esen AM
Eur J Heart Fail; 2011 Mar; 13(3):284-91. PubMed ID: 21106544
[TBL] [Abstract][Full Text] [Related]
3. Grading functional mitral regurgitation by tissue Doppler-derived isovolumic acceleration parameters in patients with nonischemic dilated cardiomyopathy.
Karaahmet T; Tigen K; Gurel E; Cevik C; Dundar C; Fotbolcu H; Pala S; Basaran Y
Echocardiography; 2010 Aug; 27(7):815-22. PubMed ID: 20546008
[TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
[TBL] [Abstract][Full Text] [Related]
5. Elevated uric acid and functional mitral regurgitation in dilated cardiomyopathy.
Yazicioğlu MV; Avci A; Açar G; Esen Ö; Karaca O; Alici G; Özkan B; Alizade E; Bulut M; Akçakoyun M; Esen AM
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1637-41. PubMed ID: 23161034
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
[TBL] [Abstract][Full Text] [Related]
7. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
Tigen K; Karaahmet T; Tanalp AC; Gurel E; Cevik C; Mutlu B; Basaran Y
Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
[TBL] [Abstract][Full Text] [Related]
8. Change of B-type natriuretic peptide after surgery and its association with rhythm status in patients with chronic severe mitral regurgitation.
Hwang IC; Kim DH; Kim YJ; Kim KH; Lee SP; Kim HK; Sohn DW; Oh BH; Park YB
Can J Cardiol; 2013 Jun; 29(6):704-11. PubMed ID: 23218467
[TBL] [Abstract][Full Text] [Related]
9. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
10. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation.
Pizarro R; Bazzino OO; Oberti PF; Falconi M; Achilli F; Arias A; Krauss JG; Cagide AM
J Am Coll Cardiol; 2009 Sep; 54(12):1099-106. PubMed ID: 19744620
[TBL] [Abstract][Full Text] [Related]
11. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
[TBL] [Abstract][Full Text] [Related]
12. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
[TBL] [Abstract][Full Text] [Related]
13. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
[TBL] [Abstract][Full Text] [Related]
14. Neurohormonal and echocardiographic results after CorCap and mitral annuloplasty for dilated cardiomyopathy.
Rubino AS; Onorati F; Santarpino G; Pasceri E; Santarpia G; Cristodoro L; Serraino GF; Renzulli A
Ann Thorac Surg; 2009 Sep; 88(3):719-25. PubMed ID: 19699885
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation.
Magne J; Mahjoub H; Pierard LA; O'Connor K; Pirlet C; Pibarot P; Lancellotti P
Heart; 2012 Apr; 98(7):584-91. PubMed ID: 22342982
[TBL] [Abstract][Full Text] [Related]
16. Intraventricular and papillary muscle dyssynchrony is related to the diastolic phase of functional mitral regurgitation in patients with non-ischemic dilated cardiomyopathy.
Karaahmet T; Tigen K; Dundar C; Cevik C; Guler A; Gurel E; Kirma C
J Heart Valve Dis; 2011 Mar; 20(2):136-45. PubMed ID: 21560811
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of mitral repair for functional mitral regurgitation in idiopathic dilated cardiomyopathy.
De Bonis M; Taramasso M; Verzini A; Ferrara D; Lapenna E; Calabrese MC; Grimaldi A; Alfieri O
Eur J Cardiothorac Surg; 2012 Oct; 42(4):640-6. PubMed ID: 22447810
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Bistola V; Parissis JT; Paraskevaidis I; Panou F; Nikolaou M; Ikonomidis I; Flessas N; Filippatos G; Iliodromitis E; Kremastinos DT
Am J Cardiol; 2010 Jan; 105(2):249-54. PubMed ID: 20102927
[TBL] [Abstract][Full Text] [Related]
20. Early improvement of functional mitral regurgitation in patients with idiopathic dilated cardiomyopathy.
Stolfo D; Merlo M; Pinamonti B; Poli S; Gigli M; Barbati G; Fabris E; Di Lenarda A; Sinagra G
Am J Cardiol; 2015 Apr; 115(8):1137-43. PubMed ID: 25721482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
